The primary investment objective of the scheme is to generate long term growth of capital by predominantly investing in arbitrage opportunities present between the cash and derivate markets, as well as within the derivative segment, complemented by investments in debt securities and money market instruments. However...
The investment objective of the scheme is to provide long-term capital appreciation from a portfolio investing in units of Mirae Asset Nifty India New Age Consumption ETF. The scheme does not guarantee or assure any returns. There is no assurance that the investment objective of the scheme will be achieved. This product is...
The investment objective of the scheme is to generate returns, before expenses, that are commensurate with the performance of the Nifty India New Age Consumption Total Return Index, subject to tracking error. The scheme does not guarantee or assure any returns. There is no assurance that the investment objective of the...
The objective of the scheme is to invest in companies whose securities are included in Nifty 500 Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty 500 Index in the same weightage that they represent in Nifty 500...
The investment objective of the scheme is to generate returns that are in line with the performance of the BSE Capital Markets & Insurance Total Return Index, subject to tracking errors. There is no assurance or guarantee that the investment objective of the scheme will be achieved. This product is suitable for investors who...
The investment objective of the scheme is to generate returns corresponding to the total returns of the securities as represented by the CRISIL-IBX Financial Services 3 to 6 Months Debt Index before expenses, subject to tracking errors. The scheme does not guarantee/indicate any returns. There is no assurance or guarantee...
The primary investment objective of the scheme is to generate long term growth by investing predominantly in a portfolio of equity and equity related instruments. However, there is no assurance or guarantee that the investment objective of the scheme will be achieved. This product is suitable for investors who are seeking...
The objective of the scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there is no assurance that the investment objective of the scheme will be achieved. This product is suitable for investors who...
The investment objective of the scheme is to provide investment returns before fees and expenses that closely corresponds to the total returns of the securities as represented by the CRISIL- IBX AAA NBFC-HFC Index - Jun 2027, subject to tracking error. There is no assurance that the investment objective of the scheme...
The investment objective of the scheme is to achieve long term capital appreciation by investing in equity and equity related securities of companies that follow conglomerate theme. The scheme does not guarantee/indicate any returns. There is no assurance that the investment objective of the scheme will be achieved. This...
